Substance active (DCI)
- paclitaxel (dans une formulation de nanoparticules liées à l’albumine)
Informations techniques
Présentation
PAZENIR 5 mg/mL, poudre pour dispersion pour perfusion
1 flacon en verre de 100 mg (CIP : 34009 301 845 9 2)
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
n4AM6LJF9Xj3gx5C